Identification of Interleukin (IL)-33 Inhibitory Constituents from <i>Canavalia gladiata</i> Pods

Interleukin (IL)-33, a member of the IL-1 cytokine family, plays a vital role in immune system regulation and inflammation, with oxidative stress being implicated in its expression. During the search for compounds from natural sources with potential as therapeutic agents for allergic diseases via IL...

Full description

Saved in:
Bibliographic Details
Main Authors: Le Ba Vinh (Author), Seung Hyuck Shin (Author), Yoo Kyong Han (Author), Young Jun Kim (Author), Nguyen Cao Cuong (Author), Soohwan Oh (Author), Ki Yong Lee (Author)
Format: Book
Published: MDPI AG, 2024-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d0dfa94a1b7d42e4925c92ed4989a91f
042 |a dc 
100 1 0 |a Le Ba Vinh  |e author 
700 1 0 |a Seung Hyuck Shin  |e author 
700 1 0 |a Yoo Kyong Han  |e author 
700 1 0 |a Young Jun Kim  |e author 
700 1 0 |a Nguyen Cao Cuong  |e author 
700 1 0 |a Soohwan Oh  |e author 
700 1 0 |a Ki Yong Lee  |e author 
245 0 0 |a Identification of Interleukin (IL)-33 Inhibitory Constituents from <i>Canavalia gladiata</i> Pods 
260 |b MDPI AG,   |c 2024-06-01T00:00:00Z. 
500 |a 10.3390/antiox13070767 
500 |a 2076-3921 
520 |a Interleukin (IL)-33, a member of the IL-1 cytokine family, plays a vital role in immune system regulation and inflammation, with oxidative stress being implicated in its expression. During the search for compounds from natural sources with potential as therapeutic agents for allergic diseases via IL-33 signal modulation, we discovered significant IL-33 inhibitory activity in the methanol extract of <i>Canavalia gladiata</i> (sword bean) pods. Through chromatographic separation and liquid chromatography-mass spectrometry, we isolated 11 compounds (<b>1</b>-<b>11</b>) from the methanol extract. Furthermore, we assessed the inhibitory effects of these substances on IL-33/ST2 signaling in processes related to inflammatory and autoimmune diseases using an enzyme-linked immunosorbent assay. Among them, compounds <b>7</b>, <b>10</b>, and <b>11</b> exhibited substantial IL-33 inhibitory efficacy, with values reaching 78%, 86%, and 79% at 100 µM, respectively. Remarkably, compounds <b>7</b>, <b>10</b>, and <b>11</b> demonstrated significant and dose-dependent inhibition of IL-33 signaling at concentrations of 10, 50, and 100 µM. Computational molecular docking and dynamic simulations further elucidated the underlying mechanisms. These findings have promising pharmacological implications for allergy prevention and treatment associated with flavonoid glycosides derived from <i>C. gladiata.</i> 
546 |a EN 
690 |a <i>Canavalia gladiata</i> 
690 |a sword bean pods 
690 |a interleukin-33 
690 |a molecular docking 
690 |a molecular dynamic 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Antioxidants, Vol 13, Iss 7, p 767 (2024) 
787 0 |n https://www.mdpi.com/2076-3921/13/7/767 
787 0 |n https://doaj.org/toc/2076-3921 
856 4 1 |u https://doaj.org/article/d0dfa94a1b7d42e4925c92ed4989a91f  |z Connect to this object online.